Target intelligence / Profile preview

Fungal cell wall components

Molecular classification
Polysaccharide, Glycoprotein, Carbohydrate
01

Overview

The fungal cell wall is a complex and dynamic structure essential for the survival, growth, and virulence of fungal pathogens. It is primarily composed of a cross-linked network of polysaccharides, including chitin, beta-glucans (specifically 1,3-beta-D-glucan and 1,6-beta-D-glucan), and various mannoproteins [1][2]. These components provide the necessary mechanical strength to withstand high internal osmotic pressure and protect the cell from environmental stressors. Because these specific carbohydrate polymers are absent in human cells, the fungal cell wall represents a highly selective target for antifungal therapy [3]. Drugs such as echinocandins (e.g., caspofungin) and the triterpenoid ibrexafungerp exert their fungicidal effects by inhibiting the synthesis of 1,3-beta-D-glucan, leading to cell wall instability and osmotic lysis [3][4]. Additionally, cell wall components like galactomannan and beta-glucan are shed into the host's bloodstream during invasive infections, serving as critical diagnostic biomarkers for early detection and monitoring of treatment efficacy [2][5]. (Citations: [1] Gow et al., 2017, Nature Reviews Microbiology; [2] Garcia-Rubio et al., 2020, Microorganisms; [3] StatPearls, 2023, Antifungal Medications; [4] NIH/NCBI, 2021, Beta-glucan Synthase Inhibitors; [5] CDC, 2022, Laboratory Diagnosis of Fungal Infections).

Other names
Fungal cell wall1,3-beta-D-glucanChitinMannoproteinGalactomannan1,6-beta-D-glucan
02

Mechanism of action

Inhibition of 1,3-beta-glucan synthase; Inhibition of chitin synthase; Disruption of cell wall polymer cross-linking

03

Biological functions

Structural integrityOsmotic pressure regulationCell shape maintenanceImmune system modulationPathogen-associated molecular pattern (PAMP) recognitionCell-cell interaction
04

Disease associations

InfectionInvasive candidiasisInvasive aspergillosisPneumocystis pneumoniaCryptococcosisMycosis
05

Safety considerations

Development of antifungal resistance (e.g., FKS gene mutations)Limited spectrum of activity against species lacking specific components (e.g., Cryptococcus)Infusion-related reactionsPotential for hepatotoxicity with certain systemic antifungals
06

Interacting drugs

Caspofungin

5 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG)Galactomannan (GM)Mannan antigen

Beyond the preview

Go deeper on Fungal cell wall components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell wall components.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call